Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Exercise/Conversion of 313 PVLA shares, $39.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | PALVELLA THERAPEUTICS, INC. (PVLA) | Exercise/Conversion | 313 | $39.8K |
| Jun 12, 2026 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 3,000 | n/a |
| Jun 11, 2025 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 12,350 | n/a |
| Dec 18, 2024 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 24,700 | n/a |
| Dec 9, 2024 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/Award | 500 | n/a |
| Jun 23, 2023 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/Award | 40,000 | n/a |
| May 30, 2023 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Purchase | 10,000 | $8.5K |
| Jun 24, 2022 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/Award | 40,000 | n/a |
| Jun 29, 2021 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/Award | 40,000 | n/a |
| Jun 25, 2020 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/Award | 40,000 | n/a |